Approaches in Cancer Therapy

Track 5:  Approaches in Cancer Therapy:

Cancer rates are daily increasing particularly in the developed world. Many cancers are associated with longevity, and as life expectancy increase the risk on patients and payers will increase. Major advances in cellular biology, genetics, pharmacology and immunology in the past ten years are beginning to be translated into progress in cancer treatment. This progress is manifested by new cell killing drugs which have recently entered clinical practice. Tumor angiogenesis as a target is being studied in several clinical trials. The emerging field of genomics and gene expression micro-arrays will provide extensive information about the biology of cancers. This is the most prestigious conference across all the Cancer Conferences and Oncology Conferences

The global market for biopsy devices is valued at over $1600 million and is expected to show a CAGR of about 7.1% from the period of 2013-2020. The European holds the second largest market share after North America. It is valued at $480 million and is showing a CAGR of about 7.04% for the next five- seven years and is expected to reach a value of $773 million by 2020. The global breast biopsy market is poised to reach $728.8 Million by 2020 from $436.4 Million in 2015, at a CAGR of 10.8% from 2015 to 2020.

 

  • Molecular targeted cancer therapy
  • Precision medicines
  • Metabolomic cancer therapy
  • Nanotechnology in cancer therapy
  • Genomic tumor assessment
  • Tumor molecular profiling
  • Androgen manipulation
  • Hormone therapies
  • Gene expression modulators
  • Small oligonucleotides therapy
  • Stem cell transplantation
  • Hematopoietic cell transplantation
  • Mass stem cells production technologies

Related Conference of Approaches in Cancer Therapy

Approaches in Cancer Therapy Conference Speakers